Patent · US Active

Compositions and methods for increasing erythropoietin (EPO) production

US9193973B2 · kind B2 · utility

0Cited by
0References
27Claims
0Family size

Assignees

Inventors

Key dates

Filing dateDec 9, 2011
Grant dateNov 24, 2015
Priority date
Expiry dateDec 9, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y114/11002
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to double-stranded ribonucleic acid (dsRNA) compositions targeting one or more EGLN genes, EGLN1, EGLN2 and/or EGLN3 and methods of using such dsRNA compositions to inhibit expression of these genes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.